Mumbai, Aug 31(UNI) Pharma Major, Ajanta Pharma has launched Eletriptan Hydrobromide Tablets in the US market through its wholly owned subsidiary Ajanta Pharma USA. It is a bioequivalent generic version of Relpax Tablets. The company has launched the product in two strengths, 20 mg and 40 mg tablets. Eletriptan Hydrobromide Tablets is part of an ever growing portfolio of products that Ajanta has developed for the US market. In total, Ajanta has 35 Abbreviated New Drug Applications (ANDAs) of which it has 19 final ANDA approvals, 2 tentative approvals, and 14 ANDAs under review with US FDA. So far it has launched 14 products in the US market. UNI JS AW1336